A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(52 sites)
United States
D3 Bio Investigative Site 0402, Orange, California D3 Bio Investigative Site 0407, Palo Alto, California D3 Bio Investigative Site 0404, Denver, Colorado D3 Bio Investigative Site 0406, Sarasota, Florida D3 Bio Investigative Site 0401, Detroit, Michigan D3 Bio Investigative Site 0405, Nashville, Tennessee D3 Bio Investigative Site 0403, Houston, Texas Australia
D3 Bio Investigative Site 0102, Sydney, New South Wales D3 Bio Investigative Site 0101, Malvern, Victoria D3 Bio Investigative Site 0105, Melbourne, Victoria D3 Bio Investigative Site 0103, Nedlands, Western Australia D3 Bio Investigative Site 0104, Bedford Park China
D3 Bio Investigative Site 0303, Beijing, Beijing Municipality D3 Bio Investigative Site 0306, Guangzhou, Guangdong D3 Bio Investigative Site 0305, Hangzhou, Hangzhou D3 Bio Investigative Site 0307, Harbin, Heilongjiang D3 Bio Investigative Site 0309, Wuhan, Hubei D3 Bio Investigative Site 0312, Wuhan, Hubei D3 Bio Investigative Site 0304, Nanchang, Jiangxi D3 Bio Investigative Site 0302, Shenyang, Liaoning D3 Bio Investigative Site 0310, Jinan, Shandong D3 Bio Investigative Site 0301, Shanghai, Shanghai Municipality D3 Bio Investigative Site 0308, Shanghai, Shanghai Municipality D3 Bio Investigative Site 0316, Chengdu, Sichuan D3 Bio Investigative Site 0311, Hangzhou, Zhejiang France
D3 Bio Investigative Site 0804, Bordeaux D3 Bio Investigative Site 0803, Lyon D3 Bio Investigative Site 0801, Rennes D3 Bio Investigative Site 0802, Villejuif Germany
D3 Bio Investigative Site 1003, Cologne, North Rhine-Westphalia D3 Bio Investigative Site 1002, Hamburg Hong Kong
D3 Bio Investigative Site 0501, Shatin Italy
D3 Bio Investigative Site 0905, Candiolo D3 Bio Investigative Site 0902, Milan D3 Bio Investigative Site 0904, Naples D3 Bio Investigative Site 0901, Rome D3 Bio Investigative Site 0903, Siena Japan
D3 Bio Investigative Site 0601, Kashiwa D3 Bio Investigative Site 0602, Tokyo South Korea
D3 Bio Investigative Site 0204, Cheongju-si, North Chungcheong D3 Bio Investigative Site 0202, Seoul D3 Bio Investigative Site 0203, Seoul D3 Bio Investigative Site 0201, Seoul Spain
D3 Bio Investigative Site 0706, Barcelona D3 Bio Investigative Site 0701, Barcelona D3 Bio Investigative Site 0704, Madrid D3 Bio Investigative Site 0705, Madrid D3 Bio Investigative Site 0703, Valencia D3 Bio Investigative Site 0702, Valencia D3 Bio Investigative Site 0315, Changsha
D3 Bio Investigative Site 0314, Hefei D3 Bio Investigative Site 0313, Zhengzhou